FDA Approval: ANZUPGO (DELGOCITINIB) — Type 1 - New Molecular Entity
Dermatology
CPT procedure code
88271 — Molecular cytogenetics; DNA probe, each
PathologyCPT
Code definition
Code
88271
Code system
CPT (Current Procedural Terminology)
Description
Molecular cytogenetics; DNA probe, each
Category
Pathology
Short description sourced from CMS publicly available fee schedule data. Full CPT descriptions are copyright AMA. Not a substitute for the official CPT codebook.
Latest reimbursement alerts
No alerts currently reference 88271 directly. Here are the latest policy changes across all codes.
Low
FDA Approval: LEQSELVI (DEURUXOLITINIB PHOSPHATE) — Type 1 - New Molecular Entity
Dermatology
FDA Approval: ONAPGO (APOMORPHINE HYDROCHLORIDE) — Type 5 - New Formulation or New Manufacturer
Neurology
Medicare Coverage Database - New Items
General
CMS Physician Fee Schedule
Physician Fee Schedule
CMS MAC Archives
General
Related CPT codes (882xx)
88230PathologyTissue culture for neoplastic disorders, lymphocyte
88233PathologyTissue culture for neoplastic disorders, skin/tissue biopsy
88237PathologyTissue culture for neoplastic disorders, bone marrow/blood
88262PathologyChromosome analysis; 15-20 cells, 2 karyotypes
88280PathologyChromosome analysis; additional karyotypes, each study
Get alerts when policy changes affect 88271
Free weekly digest — no subscription required.
Look up another code
Search ICD-10, HCPCS, or CPT codes with related reimbursement alerts.